eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST
eXoZymes (NASDAQ:EXOZ), a company specializing in AI-engineered enzymes for sustainable feedstock transformation, has announced its upcoming Q2 2025 earnings webinar. The event will take place on Tuesday, August 12, 2025, at 5:00 PM ET.
CEO Michael Heltzen and management team members will discuss quarterly results, recent developments, ongoing initiatives, and future milestones. The presentation will include a Q&A session. Investors can pre-register for the webinar or access it through the company's investor relations website on the day of the event.
eXoZymes (NASDAQ:EXOZ), azienda specializzata in enzimi progettati con intelligenza artificiale per la trasformazione sostenibile delle materie prime, ha annunciato il prossimo webinar sui risultati del secondo trimestre 2025. L'evento si terrà martedì 12 agosto 2025 alle 17:00 ET.
Il CEO Michael Heltzen e i membri del team dirigenziale discuteranno i risultati trimestrali, gli sviluppi recenti, le iniziative in corso e gli obiettivi futuri. La presentazione includerà una sessione di domande e risposte. Gli investitori possono preregistrarsi al webinar o accedervi tramite il sito web delle relazioni con gli investitori dell'azienda il giorno dell'evento.
eXoZymes (NASDAQ:EXOZ), una empresa especializada en enzimas diseñados con inteligencia artificial para la transformación sostenible de materias primas, ha anunciado su próximo webinar de resultados del segundo trimestre de 2025. El evento tendrá lugar el martes 12 de agosto de 2025 a las 5:00 PM ET.
El CEO Michael Heltzen y los miembros del equipo directivo discutirán los resultados trimestrales, desarrollos recientes, iniciativas en curso y metas futuras. La presentación incluirá una sesión de preguntas y respuestas. Los inversores pueden preregistrarse para el webinar o acceder a él a través del sitio web de relaciones con inversores de la compañía el día del evento.
eXoZymes (NASDAQ:EXOZ)는 지속 가능한 원료 변환을 위한 AI 설계 효소 전문 기업으로, 곧 개최될 2025년 2분기 실적 웨비나를 발표했습니다. 행사는 2025년 8월 12일 화요일 오후 5시(동부 시간)에 진행됩니다.
CEO 마이클 헬첸과 경영진이 분기 실적, 최근 개발 사항, 진행 중인 이니셔티브 및 향후 목표에 대해 논의할 예정입니다. 발표 후 질의응답 시간이 마련됩니다. 투자자들은 웨비나 사전 등록을 하거나 행사 당일 회사 투자자 관계 웹사이트를 통해 접속할 수 있습니다.
eXoZymes (NASDAQ:EXOZ), une entreprise spécialisée dans les enzymes conçues par intelligence artificielle pour la transformation durable des matières premières, a annoncé son prochain webinaire sur les résultats du deuxième trimestre 2025. L'événement aura lieu le mardi 12 août 2025 à 17h00 ET.
Le PDG Michael Heltzen et les membres de l'équipe de direction discuteront des résultats trimestriels, des développements récents, des initiatives en cours et des objectifs futurs. La présentation comprendra une session de questions-réponses. Les investisseurs peuvent s'inscrire à l'avance au webinaire ou y accéder via le site web des relations investisseurs de la société le jour de l'événement.
eXoZymes (NASDAQ:EXOZ), ein Unternehmen, das sich auf KI-entwickelte Enzyme für die nachhaltige Rohstoffumwandlung spezialisiert hat, hat sein bevorstehendes Q2 2025 Ergebnis-Webinar angekündigt. Die Veranstaltung findet am Dienstag, den 12. August 2025, um 17:00 Uhr ET statt.
CEO Michael Heltzen und Mitglieder des Managementteams werden die Quartalsergebnisse, aktuelle Entwicklungen, laufende Initiativen und zukünftige Meilensteine besprechen. Die Präsentation beinhaltet eine Fragerunde. Investoren können sich vorab für das Webinar registrieren oder am Veranstaltungstag über die Investor-Relations-Website des Unternehmens teilnehmen.
- None.
- None.
LOS ANGELES, CA / ACCESS Newswire / August 7, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - plans to host a webinar on Tuesday, August 12, 2025 at 5:00 PM Eastern Time to discuss its results for the second quarter of 2025.
Michael Heltzen, CEO of eXoZymes, will lead the call and will be joined by select members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer session.
Investors can pre-register now for the webinar HERE. The live webinar can also be accessed on the day of the event through eXoZymes' investor relations website at https://exozymes.com/investor#webinar
About eXoZymes
Founded in 2019, the company has developed a biomanufacturing platform that - as a historic first - offers the tools and insights to design, engineer, control and optimize nature's own natural processes to produce chemical compounds, enabling the company's partners to upgrade traditional petro-chemical production methods with a new commercially scalable, sustainable, and eco-friendly alternative: exozymes.
Exozymes are advanced enzymes enhanced through AI and bioengineering to thrive in a bioreactor without using living cells. Exozymes can replace toxic petrochemical processes and inefficient biochemical extraction with sustainable and scalable biosolutions that transform biomass into essential chemicals, medicines, and biofuels.
By freeing enzyme-driven chemical reactions from the limitations imposed by cells, exozyme biosolutions eliminate the scaling bottleneck that has hampered commercial success in the synthetic biology (SynBio) space, making exozymes the next generation of biomanufacturing.
While the company, eXoZymes Inc., has introduced "exozymes" as a scientific concept, they are not trademarking the concept, as they view it as a new nomenclature for wide adoption for this next generation of biomanufacturing that eXoZymes aims to pioneer and be the market leader of.
Learn more on exozymes.com
eXoZymes Safe Harbor
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements, which are based on certain assumptions and describe the company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely," "potential," or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Actual results could differ materially for a variety of reasons. You should carefully consider the risks and uncertainties described in the "Risk Factors" section of eXoZymes' quarterly reports on Form 10-Q, annual reports on Form 10-K, and other documents filed by eXoZymes from time to time by the company with the Securities and Exchange Commission. These filings identify and address important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and eXoZymes assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. eXoZymes does not give any assurance that it will achieve its expectations.
eXoZymes Contact
Lasse Görlitz, VP of Communications
(858) 319-7135
press@exozymes.com
SOURCE: eXoZymes
View the original press release on ACCESS Newswire
FAQ
When is eXoZymes (EXOZ) Q2 2025 earnings webinar?
Who will present at the eXoZymes (EXOZ) Q2 2025 earnings call?
How can investors access eXoZymes (EXOZ) Q2 2025 earnings webinar?
What will be discussed during eXoZymes (EXOZ) Q2 2025 earnings call?
What does eXoZymes (EXOZ) company do?
